A Multicenter Randomized Controlled Open-label Trial of Tenofovir vs. Tenofovir Plus Entecavir in Chronic Hepatitis B Patients With Genotypic Resistance to Entecavir and Partial Virologic Response to Ongoing Treatment
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 01 Jul 2015
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary) ; Entecavir
- Indications Hepatitis B
- Focus Therapeutic Use
- 24 Jun 2015 Planned End Date changed from 1 Jun 2014 to 1 Jun 2018 as reported by ClinicalTrials.gov.
- 25 Nov 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 01 Sep 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.